Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review
Guillain-Barré syndrome (GBS) is a rare but severe complication of COVID-19 vaccination. We report two cases of GBS following vaccination with the adenovirus vector vaccine ChAdOx1 nCoV-19 (Vaxzevria, AstraZeneca) and review the relevant literature. Relevant studies published between December 2020 a...
Saved in:
Main Authors: | Hsin-Yu Lee (Author), Wan-Ching Lien (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 vaccine type and Guillain-Barré syndrome: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023) -
Post COVID-19 vaccination Guillain-Barre syndrome: three cases
by: Seyedehnarges Tabatabaee, et al.
Published: (2022) -
Guillain-Barré Syndrome in the COVID-19 Pandemic
by: Abdullah Ahmad Tawakul, et al.
Published: (2021) -
A case of Guillain-Barre syndrome following Pfizer COVID-19 vaccine
by: Shiavax J. Rao, et al.
Published: (2021) -
A Case of Guillain-Barré Syndrome Associated With COVID-19
by: Kartikeya Rajdev MBBS, et al.
Published: (2020)